CIBRA Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-99,250
Closed -$3.12M – 31
2026
Q2
$3.12M Buy
+99,250
New +$2.93M 1.38% 20

Other funds holding CPRX

CIBRA Capital's CPRX Position: Q3 2026 in Review

CIBRA Capital sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 99,250 shares — an estimated $3.12M sold.

CIBRA Capital first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $3.12M in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

  • CIBRA Capital reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • CIBRA Capital sold 99,250 Catalyst Pharmaceutical shares in Q3 2026, an estimated $3.12M.
  • CIBRA Capital first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • CIBRA Capital's Catalyst Pharmaceutical position peaked at $3.12M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on CIBRA Capital's 13F filing for Q3 2026, filed 19 Nov 2026.